Health Canada
Symbol of the Government of Canada
About Health Canada

Foreign Product Alerts 2012

  • Jan
  • Feb
  • Mar
  • Apr
  • May
  • June
  • July
  • Aug
  • Sept
  • Oct
  • Nov
  • Dec

Past Foreign Product Alerts


Health Canada is advising consumers not to use the products specified below due to concerns about possible side-effects.

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace. However, it is possible these products could be purchased by Canadians travelling abroad or have been brought into Canada through personal importation by travellers or purchased over the Internet.

Canadians who have these products are advised not to use them, and should consult with a health care professional if they have concerns about their health related to the use of these products. More info

January

  • 17 weight loss products (see Alert for a complete list) [2012-01-25]
    The U.S. Food and Drug Administration warned consumers not to use 17 weight loss products after they were found to contain undeclared sibutramine, and in some cases, phenolphthalein. Sibutramine and phenolphthalein are no longer authorized in Canada for safety reasons.
  • Athri-Eze - Sear Heang Tienchi Tu Chung Wan - Wiku Jahe Kencur (Akur Mujarab) - Cap Wijaya Kusuma (An Ki It) [2012-01-25]
    The Singapore Health Sciences Authority warned consumers not to use these products after they were found to contain undeclared prescription and over-the-counter drugs (dexamethasone, prednisolone, furosemide, allopurinol, acetaminophen and/or chlorpheniramine). One product was found to contain phenylbutazone, which is no longer authorized in Canada due to safety reasons. Prescription drugs should only be taken under the supervision of a health care practitioner.
  • Ying Da Wang tablets [2012-01-25]
    The Australian Therapeutic Goods Administration warned consumers not to use this product after it was found to contain undeclared sildenafil, which is a prescription drug used to treat erectile dysfunction and should only be taken under the supervision of a health care practitioner.
  • Get Stiff - Maxi Mize [2012-01-25]
    New Zealand's Medsafe warned consumers not to use these products after they were found to contain undeclared substances that are similar to prescription drugs and may pose similar health risks (hydroxyhomosildenafil, hydroxythiohomosildenafil), and/or prescription drugs that should only be used under the supervision of a health care practitioner (tadalafil, vardenafil, yohimbine).
  • Uprizing 2.0 [2012-01-25]
    The U.S. Food and Drug Administration informed consumers of a company recall after Uprizing 2.0 was found to contain undeclared superdrol, a synthetic anabolic steroid. In Canada, anabolic steroids are controlled substances and are therefore only legally available by prescription. They should only be taken under the supervision of a health care practitioner.
  • Slimina weightloss capsules, S-shape slim capsules [2012-01-25]
    The Australian Therapeutic Goods Administration warned consumers not to use these products after Slimina weightloss capsules was found to contain undeclared sibutramine while S-shape slim capsules was found to contain undeclared sibutramine, fenfluramine, phenolphthalein, propranolol and nifedipine. Some of these pharmaceutical ingredients are no longer authorized in Canada for safety reasons (sibutramine, fenfluramine and phenolphthalein), while others are prescription drugs and should only be taken under the supervision of a health care practitioner (propranolol and nifedipine).
  • [LuShenPai] Specific Hou Ton Qing, [AA] Pe Min Kan Wan [2012-01-25]
    The Hong Kong Department of Health warned consumers to not use these products after they were found to contain excessive levels of arsenic or mercury, which are heavy metals. Ingestion of excessive amounts of heavy metals poses serious health risks because they may accumulate in vital organs of the body. Children are most susceptible to the toxic effects.
  • Cardiotium - Paidusu - SlimEasy Herbs Capsule - Tianran Zuanshi Xianweisu [2012-01-25]
    The Hong Kong Department of Health warned consumers not to use these products after they were found to contain undeclared pharmaceutical substances (losartan, atorvastatin, thyroxine, sibutramine and/or phenolphthalein). These substances are prescription drugs and should only be used under the supervision of a health care practitioner (losartan, atorvastatin, thyroxine), or they are no longer authorized in Canada for safety reasons (sibutramine and phenolphthalein).

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find any of the products listed above in the Canadian marketplace.

For more information about the information contained in this advisory, please contact Health Canada's public enquiries line at (613) 957-2991 or toll-free at 1-866-225-0709.

As of the date of this posting, no adverse reactions suspected to be associated with the use of these products have been reported in Canada.

To report a suspected adverse reaction, please visit the MedEffect Adverse Reaction Reporting page.